Thalidomide attenuates the development and expression of antinociceptive tolerance to μ-opioid agonist morphine through l-arginine-iNOS and nitric oxide pathway

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.

André L. Moreira, E P Sampaio, A Zmuidzinas et al. · The Journal of Experimental Medicine · 1993 · 1.1K citations · Full text

Life Sciences, Immunology, Pharmacology +14

Thalidomide in the treatment of lepra reactions

J Sheskin · Clinical Pharmacology & Therapeutics · 1965 · 533 citations

Medicine, Dermatology, Infectious Diseases +7

cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.

Marı́a A. Moro, Raisul Russel, Selim Cellek et al. · Proceedings of the National Academy of Sciences · 1996 · 472 citations

Medicine, Pharmacology, Biochemical Pharmacology +14

The Influence of Thalidomide on the Clinical and Immunologic Manifestation of Erythema Nodosum Leprosum

Elizabeth P. Sampaio, Gilla Kaplan, Antônio Basílio de Miranda et al. · The Journal of Infectious Diseases · 1993 · 372 citations

Medicine, Dermatology, Immunology +17

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

JN Gordon · Gut · 2005 · 320 citations · Full text

Medicine, Oncology, Pharmacology +9